Naiyer A. Rizvi
Western University(CA)Columbia University Irving Medical Center(US)Menlo School(US)Synthego (United States)(US)Synthomics (United States)(US)Columbia University(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer(2015)9,390 cited
- → Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer(2015)7,863 cited
- → Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer(2015)6,153 cited
- → Tumor mutational load predicts survival after immunotherapy across multiple cancer types(2019)4,299 cited
- → Nivolumab plus Ipilimumab in Advanced Melanoma(2013)4,206 cited
- → Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade(2016)3,055 cited